Ridgeback Capital Investments as of June 30, 2012
Portfolio Holdings for Ridgeback Capital Investments
Ridgeback Capital Investments holds 17 positions in its portfolio as reported in the June 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ironwood Pharmaceuticals (IRWD) | 30.4 | $33M | 2.4M | 13.78 | |
Ariad Pharmaceuticals | 13.6 | $15M | 850k | 17.21 | |
Santarus | 12.7 | $14M | 1.9M | 7.09 | |
Celldex Therapeutics | 11.6 | $13M | 2.4M | 5.18 | |
Array BioPharma | 6.2 | $6.7M | 1.9M | 3.47 | |
Auxilium Pharmaceuticals | 5.6 | $6.1M | 225k | 26.89 | |
Onyx Pharmaceuticals | 4.5 | $4.8M | 73k | 66.46 | |
Sunesis Pharmaceuticals | 3.8 | $4.1M | 1.4M | 2.87 | |
Regeneron Pharmaceuticals (REGN) | 3.7 | $4.0M | 35k | 114.22 | |
Synta Pharmaceuticals | 2.1 | $2.2M | 411k | 5.47 | |
Dynavax Technologies Corporation | 2.0 | $2.2M | 500k | 4.32 | |
Sangamo Biosciences (SGMO) | 1.9 | $2.1M | 373k | 5.52 | |
Questcor Pharmaceuticals | 1.2 | $1.3M | 25k | 53.24 | |
Biolinerx Ltd-spons | 0.2 | $232k | 95k | 2.44 | |
Lexicon Pharmaceuticals | 0.2 | $225k | 100k | 2.25 | |
XenoPort | 0.1 | $139k | 23k | 6.02 | |
DUSA Pharmaceuticals | 0.1 | $90k | 17k | 5.23 |